Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Income Statement [Abstract]
Revenues	$ 4,621	$ 5,798
Cost of revenues (including depreciation of $1 and $6 in the three months ended March 31, 2025 and 2024, respectively)	1,258	1,988
Gross profit	3,363	3,810
Operating expenses:
Selling and marketing	1,643	2,614
Research and development	2,857	3,989
General and administrative	2,724	2,756
Depreciation and amortization	1,349	1,908
Goodwill impairment	0	23,989
Total operating expenses	8,573	35,256
Operating loss	(5,210)	(31,446)
Other income (expense):
Change in fair value of warrant liabilities	123	185
Interest (expense) income, net	(25)	74
Other (expense) income, net	(65)	219
Loss before provision for income tax provision	(5,177)	(30,968)
Provision for income tax expense	1	39
Net loss	$ (5,178)	$ (31,007)
Loss per share:
Basic (in dollars per share)	$ (0.28)	$ (3.28)
Diluted (in dollars per share)	$ (0.28)	$ (3.28)
Weighted average shares outstanding:
Basic (in shares)	18,216	9,466
Diluted (in shares)	18,216	9,466